# FDA Inspection 1026888 - Naval Hospital Jacksonville - September 19, 2017

Source: https://www.keypedia.com/records/fda_inspections/naval-hospital-jacksonville/249dc6d4-fbde-4fba-a685-7a5307bb9fe3
Source feed: FDA_Inspections

> FDA Inspection 1026888 for Naval Hospital Jacksonville on September 19, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1026888
- Company Name: Naval Hospital Jacksonville
- Inspection Date: 2017-09-19
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1233530 - 2024-03-05](https://www.keypedia.com/records/fda_inspections/naval-hospital-jacksonville/5ee54155-aa9f-433d-ae6e-73d38be66baf)
- [FDA Inspection 1117893 - 2019-12-09](https://www.keypedia.com/records/fda_inspections/naval-hospital-jacksonville/bacca13c-8ce9-40e9-9eb0-e90ecca5ad15)
- [FDA Inspection 945563 - 2015-10-15](https://www.keypedia.com/records/fda_inspections/naval-hospital-jacksonville/e68c68a4-7e5d-4b3d-bce8-16b7563509af)
- [FDA Inspection 844277 - 2013-08-14](https://www.keypedia.com/records/fda_inspections/naval-hospital-jacksonville/5fe6c587-135c-4375-bf77-469e750e5eb1)
- [FDA Inspection 714463 - 2011-03-16](https://www.keypedia.com/records/fda_inspections/naval-hospital-jacksonville/b32450c0-27a1-49a0-9511-df32030e7e26)

Company: https://www.keypedia.com/companies/naval-hospital-jacksonville/55ccf296-4c12-40cd-a941-1073725c3aa0

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d